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LETTERS TO THE EDITOREXPERIMENTAL DESIGN FOR
OPTIMAL FLOW RATE OF
ANTEGRADE CEREBRAL
PERFUSION
To the Editor:
We read with great interest the re-
cent article by Sasaki and colleagues.1
The purpose of this neonatal animal
investigation was to determine the opti-
mal flow rate of antegrade cerebral per-
fusion (ACP) during deep hypothermic
circulatory arrest (DHCA). Sasaki and
colleagues should be congratulated,
and we believe that their study is
a good attempt to use varied flow rates
to filtrate the optimal flow rate of ACP
during DHCA in this neonatal model.
For the past decade, surgical and
perfusion techniques have been devel-
oped to repair complex intracardiac
and aortic arch lesions during cardio-
pulmonary bypass (CPB) without us-
ing DHCA. When aortic arch surgery
is needed, modification of systemic
arterial cannulation and perfusion
techniques are required. Combined
ACP with DHCA has been advocated
in complex congenital and arch repairs
in recent years.2 However, several is-
sues remain unresolved relating to
the optimal management of the stan-
dard set of variables associated with
perfusion practice when contemplat-
ing the use of ACP during DHCA.
Technical issues relating to the use of
hypothermic ACP, such as the perfus-
ate temperature, the flow rate, and the
pressure used to selectively perfuse
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The Journaldard methods of evaluation will likely
clarify many of these issues as experi-
ence and investigations continue. It is
hard to make a conclusion about the
optimal flow for ACP at low tempera-
tures based on the existing literature.
In this particular study the authors
tried to use the neonatal animal model
to filtrate the optimal ACP flow rate
during DHCA, and they concluded
that an ACP flow rate that closely
matches standardCPB conditions is be-
tween 30 and 50mL $ kg1 $min1.We
would like to make several comments
concerning the experimental design of
this investigation. First, the authors
mentioned that during neonatal deep
hypothermic (18C to 20C) CPB, a to-
tal body flow rate is commonly used in
practice as a standard flow rate, and
they cited another clinical study for
supporting this flow rate (100 mL $
kg1 $ min1) as a baseline. However,
we did not find any descriptions using
a 100 mL $ kg1 $ min1 flow rate at
18C to 20C in the cited article3 but
rather a 30% to 50% body full-flow
rate at 18C. Nevertheless, this issue
can be easily resolved. By using the
Q10 relationship, which links meta-
bolic rate to temperature, it is possible
to estimate body flow requirements at
various degrees of hypothermia.
Second, the authors used 3 different
ACP flow rates in every single model
during DHCA. Although they adopted
random order and maintained the dura-
tion of every flow rate for 15 minutes
to avoid errors in the experimental de-
sign, we believe several limitations
must be considered in this experimental
design that might have an effect on the
results as well. The model they used in
this experiment was not identical with
the pediatric clinical setup. It is impossi-
ble to switch different ACP flow rates at
15-minute intervals in a clinical setup
during DHCA. The duration of ACP in
this model should have been much lon-
ger with a varied flow rate because the
total ACP time in a clinical situation is
shorter than this with a consistent flow
rate. Moreover, because of using 3 dif-
ferent flow rates in the same animal,of Thoracic and Cardiovascular Surgeinvestigating cerebral histology after
ACP is not meaningful, and thus the au-
thors did not use histologic comparison,
even though they separate brain issue. In
our opinion a better experimental design
would be identicalwith the clinical setup
and repeatable, yielding results more
closely aligned with clinical experience.
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MITRAL–AORTIC
INTERVALVULAR FIBROSA
To the Editor:
I read with great interest the case
presentation titled ‘‘Mitral–Aortic
Intervalvular Fibrosa Pseudoaneurysm
Resulting in the Displacement of the
Left Main Coronary Artery after Aortic
Valve Replacement’’ by Kim and
Chung1 in this Journal. They presented
the case historyof amale patientwith an-
gina and previous infectious disease in
whom infective endocarditis of the aortic
valve developed. Then he underwent
aortic valve replacement surgery with
a mechanical valve. Late after surgery,
angina pectoris occurred and a large
pseudoaneurysm in the mitral–aortic
intervalvular fibrosa (MAIVF) wasry c Volume 140, Number 3 721
